As demonstrated by Yan et al. (2024), hypoxia‒mediated SRY-box transcription factor 9 (SOX9) lactylation enhanced stemness, migratory capacity, and invasiveness in NSCLC cells by activating EMT pathways (Yan et al., 2024). This evidence concerns the gene SOX9 and non-small cell lung carcinoma.